The conference stressed a multi-dimensional approach required to address Antimicrobial Resistance (AMR), focusing on the right approach and strengthening awareness
Reinforcing commitment to ethical and sustainable growth
Minister releases five breakthrough veterinary technologies to strengthen diagnostics and combat antimicrobial resistance
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
This global affiliation marks a critical step in the company’s mission to create long-term value through ethical practices, scientific innovation, and inclusive healthcare delivery
MET-X, a novel metallo-beta-lactamase (MBL) inhibitor, has shown best-in-class performance in preclinical studies
EMBLAVEOTM is the first and only monobactam/?-lactamase inhibitor combination antibiotic therapy approved by the USFDA
The overall clinical efficacy of Zaynich across indications was 98% at the test-of-cure
AMR poses a critical threat to global public health undermining decades of progress made in the field of modern medicine
Subscribe To Our Newsletter & Stay Updated
